Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-1995 | 11-1994 | 08-1994 | 05-1994 | 02-1994 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 23,971 | N/A | N/A | N/A | 16,804 |
| Depreciation Amortization | 3,110 | N/A | N/A | N/A | 2,995 |
| Other Working Capital | -16,035 | N/A | N/A | N/A | -2,921 |
| Other Operating Activity | 2,059 | 0 | 0 | 0 | 654 |
| Operating Cash Flow | $13,105 | $N/A | $N/A | $N/A | $17,532 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,243 | N/A | N/A | N/A | -7,446 |
| Other Investing Activity | -2,698 | 0 | 0 | 0 | -253 |
| Investing Cash Flow | $-9,941 | $N/A | $N/A | $N/A | $-7,698 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,136 | 0 | 0 | 0 | 34,169 |
| Financing Cash Flow | $1,136 | $N/A | $N/A | $N/A | $34,169 |
| Beginning Cash Position | 44,854 | N/A | N/A | N/A | 851 |
| End Cash Position | 49,154 | N/A | N/A | N/A | 44,854 |
| Net Cash Flow | $4,299 | $N/A | $N/A | $N/A | $44,003 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,105 | N/A | N/A | N/A | 17,532 |
| Free Cash Flow | 13,105 | 0 | 0 | 0 | 17,532 |